Creative Planning
HUMA icon

Creative Planning’s Humacyte HUMA Stock Holding History

Creative Planning’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.8K Buy
105,119
+49,204
+88% +$51.2K ﹤0.01% 3964
2025
Q4 		$53.7K Buy
55,915
+11,903
+27% +$16.9K ﹤0.01% 3797
2025
Q3 		$76.6K Buy
+44,012
New +$86.2K ﹤0.01% 3708

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Creative Planning's HUMA Position: Q1 2026 in Review

Creative Planning increased its Humacyte (HUMA) stake by 88% in Q1 2026, buying an estimated $51.2K and bringing the position to 105,119 shares worth $63.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3964.

Creative Planning first reported a position in HUMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $76.6K in Q3 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Creative Planning held 105,119 shares of Humacyte worth $63.8K as of Q1 2026.
  • Creative Planning bought 49,204 Humacyte shares in Q1 2026, an estimated $51.2K.
  • Humacyte made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3964 holding.
  • Creative Planning first reported a position in Humacyte in Q3 2025 and has held it in 3 quarters since.
  • Creative Planning's Humacyte position peaked at $76.6K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.